These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 416316)
1. [A new 2-phase coronary agent for the treatment of angina pectoris due to coronary disease]. Gill E Med Welt; 1978 Mar; 29(10):408-11. PubMed ID: 416316 [No Abstract] [Full Text] [Related]
2. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial]. Di Prisco AU; Vaccari GL; Soro A; Mora A Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905 [TBL] [Abstract][Full Text] [Related]
4. [Comparative study of the treatment of angina pectoris with nitrong, papaverine, erinit and euphylline]. Volkov VS; Bratoliubov VP Sov Med; 1985; (7):77-80. PubMed ID: 3934766 [No Abstract] [Full Text] [Related]
5. [Evaluation of the therapeutic efficacy of 4 different delayed-action nitro-derivatives on S-T changes after exercise tests]. Roncarolo PL; Falcone M; Gabasio C; Aletto C; Guasone V; Allegri M; Giordano MP Minerva Cardioangiol; 1978 Sep; 26(9):615-8. PubMed ID: 100745 [No Abstract] [Full Text] [Related]
6. Effects of perhexiline maleate in patients with angina pectoris unrelieved by other antianginal agent. Alcocer L; Aspe J; Arce-Gomez E Curr Ther Res Clin Exp; 1973 Jul; 15(7):349-57. PubMed ID: 4198295 [No Abstract] [Full Text] [Related]
7. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged]. Gatti A; Scotti G Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306 [No Abstract] [Full Text] [Related]
8. [Combination therapy of angina pectoris vera with coronary active substances and Faustan]. Nossing R; Gruber G; Schmidt P Z Arztl Fortbild (Jena); 1971 Jun; 65(12):589-91. PubMed ID: 5000186 [No Abstract] [Full Text] [Related]
9. [Clinical considerations on the use of an antispastic-antivagal drug association in the cholecysto-coronary syndrome]. Cristiano P; Panzitta S; Cuiuli V; Petronio A; Giraldi A Minerva Gastroenterol; 1973; 19(4):259-69. PubMed ID: 4592525 [No Abstract] [Full Text] [Related]
10. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency]. Borroni G Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972 [No Abstract] [Full Text] [Related]
11. [Clinical experience with the association of a beta-blocking agent and pentaerythrite]. Barbi G; Tallone G Minerva Cardioangiol; 1969 Feb; 17(2):139-41. PubMed ID: 5777637 [No Abstract] [Full Text] [Related]
13. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate]. Rossi PL; Guarraggi A; Anfossi F Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948 [No Abstract] [Full Text] [Related]
14. [Current problems in the medical treatment of coronary insufficiency]. Cunescu V; Pîrvu V Med Interna (Bucur); 1968 Aug; 20(8):899-905. PubMed ID: 4975788 [No Abstract] [Full Text] [Related]
15. [Differential treatment of coronary heart disease]. Weser C; Scheidler K Z Arztl Fortbild (Jena); 1974 Jul; 68(13):647-53. PubMed ID: 4216180 [No Abstract] [Full Text] [Related]
16. [Conservative therapy of angina pectoris]. Nager F Schweiz Med Wochenschr; 1970 May; 100(20):855-61. PubMed ID: 4997632 [No Abstract] [Full Text] [Related]
18. [Clinical results of the use of a new drug association in heart diseases]. Chierici F; Artuso P; Suriani L Clin Ter; 1970 Feb; 52(3):219-57. PubMed ID: 5419244 [No Abstract] [Full Text] [Related]
19. [The drug therapy effect on functional and organic stenocardias]. Gill E Med Klin; 1966 Aug; 61(32):1258-60. PubMed ID: 4870033 [No Abstract] [Full Text] [Related]
20. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency]. Ballerini A Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515 [No Abstract] [Full Text] [Related] [Next] [New Search]